NEWS
Tags: 

Symyx Technologies acquires Integrity Biosolution

Symyx has acquired Integrity Biosolution in an all-cash transaction.

Integrity Biosolution provides contract formulation research and analytical services, providing solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Specific terms of the acquisition were not disclosed.

The acquisition expands Symyx's Research Service offerings in life sciences into biologic formulations, complementing its existing chemical formulations services. The combination of Symyx and IntegrityBio creates a differentiated set of large molecule formulation services to customers in the pharmaceutical and biotechnology industries by combining IntegrityBio's formulation expertise with Symyx's advanced high-throughput research and informatics capabilities.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Sophia Ktori investigates the use of informatics software to increase data integrity in the laboratory

Feature

Tim Gillett reports from PRACEDays 2016, held in May in the city of Prague

Feature

Robert Roe investigates the motivation behind the architectural changes to Europes fastest supercomputer, Piz Daint, housed at the Swiss National Computing Centre

Feature

Robert Roe discusses the merits of the latest storage technologies, including a push by storage providers to develop end-to-end platforms featuring intelligent data management systems

Feature

As AMD launches its latest FirePro GPU, Robert Roe investigates a new suite of open-source tools, released by the company that convert code from CUDA into C++